Welcome OSET 2020 Attendees!
Faster Healing. Faster Recovery. Faster Return to Daily Life.
Support regenerative healing and functional recovery1 with the Amniox Family of Umbilical Cord Allografts, the go-to adjunctive therapy for surgical and chronic wound procedures.
Learn more about how our umbilical cord allografts deliver the natural properties of human birth tissue 1 to help manage and prevent complications in most complex surgical procedures.2-16
Developed by pioneers in the field of regenerative medicine, CLARIX cryopreserved umbilical cord matrix delivers the benefits of amniotic tissue to facilitate the healing process across a range of surgical specialties.
With CLARIX, you’re able to transplant more of this innate biology to each surgical site, thus supporting a more structured healing environment, helping to manage regenerative healing, and facilitating your patient’s functional recovery.
CLARIX FLO umbilical cord based injectable, supports the management of clinically impactful outcomes1 without the potential complications associated with repeated steroid injections or unclear benefits of PRP. It offers immediate cushioning that helps create a regenerative healing environment.
With the umbilical cord as its primary platform, the NEOX family of products are used to manage chronic and complex wounds. NEOX is designed to meet the needs of clinicians and patients and comes in a variety of sizes, formulations and storage options.
Downloadable Resources
form
Exclusively for OSET 2020 Attendees
Supports decreased wound dehiscence and scar tissue formation to facilitate expedited wound healing and functional recovery16-24
Aids in reducing adhesion formation, and facilitates restoration of range of motion after tendon repair surgery and other soft tissue procedures17,23
UP TO 10X THICKER than amniotic membrane,25,26 which may increase longevity in the surgical site
Promote Regenerative Healing, Backed by Research
Our extensive research allows us to preserve and deliver the most functional allograft for your needs.
500K
Transplants
360
Clinical Publications
30Y
Research & Development
The Science Behind Our Products
The Amniox Family of Cryopreserved Umbilical Cord Allografts helps deliver the natural properties of human birth tissue to wound environments.1
We have a wide range of adjunct therapies for the management of regenerative healing and functional recovery of surgical, acute and chronic wounds.
Learn about the science behind our platform in the video below:
Exclusive Access to the Physician Portal
We take pride in what our advanced platform technology can do in the most complex medical conditions, as well as the vast body of scientific and clinical research which backs its use. The Physician Portal includes a variety of valuable educational resources to help you become more comfortable with our game-changing products so you may readily apply them in your clinical practice. Click Here to Access the Physician Portal
See What Others Are Saying about Amniox
Robert Anderson, M.D.
Titletown Sports Medicine and Orthopedics
Green Bay, WI
In this short excerpt from a recent webinar, Dr. Robert Anderson, Foot & Ankle specialist and Co-chair of the NFL’s Musculoskeletal Committee, shares his perspective and experience on the adoption of umbilical cord allografts in sports-related foot and ankle surgical procedures.
Gregory C. Berlet, M.D.
Orthopedic Foot and Ankle Center
Columbus, OH
Surgical Repair of the Peroneus Brevis Tendon
WILLIAM MARSTON, MD
Professor of Surgery and Chief Division of Vascular Surgery
University of North Carolina School of Medicine
Chapel Hill, NC
Watch Dr. William Marston as he presents the 1-year follow-up results to the Phase 2 Clinical Trial results for Amniox’s investigational new drug TTAX01.
